跳至主要内容
临床试验/CTRI/2023/11/059680
CTRI/2023/11/059680招募中Unknown

Estimation of salivary and tumor derived chemerin and tissue CD34 for early diagnosis and prognostication of patients with oral squamous cell carcinoma - NI

Pavithra V0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • For Tissues
  • Group 1 Well Diffrentiated Oral Squamous Cell Carcinoma
  • Group2 Moderate and Poorly Diffrentiated Oral Squamous Cell Carcinoma
  • Group 1 Well,Moderate,Poorly differentiated and recurrent cases of Oral Squamous Cell Carcinoma
  • Group 2 Premalignant lesions showing moderate and severe dysplasia
  • Group 3 Clinically healthy individuals without any systemic diseases

排除标准

  • Patients with systemic diseases, inflammatory oral lesions, periodontal disease, Prior history of other malignancy, Prior treatment in the form of chemotherapy, radiotherapy, Pregnancy, Lactating mothers, Patients who are obese (BMI =30).

研究者

发起方
Pavithra V

相似试验